Revenue
5.17 thousand USD
2020 Q1 · USD
Exact inputs and evidence
- Revenue: 5167 USD Source
Fundies. English
Vilacto Bio Inc.
EDGAR32 filing records in this dataset, filed from 2013-05-15 to 2019-08-20. Reported financial figures are available; chart coverage varies by period.
Latest quarter
- Cash and cash equivalents
- 121 thousand USD Source
Exact value
120731 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 1.91 billion shares Source
Exact value
1914431324 shares
Reported share-count change
2,027.15% · 1.82 billion shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
9.63 thousand USD
2018-07-01 – 2019-06-30
Operating cash flow
-652 thousand USD
2018-07-01 – 2019-06-30
Exact inputs and evidence
- Operating cash flow: -296244 USD · 2018-04-01 – 2018-09-30 Source
- Operating cash flow: -101935 USD · 2018-04-01 – 2018-06-30 Source
- Operating cash flow: -482875 USD · 2018-04-01 – 2018-12-31 Source
- Operating cash flow: -296244 USD · 2018-04-01 – 2018-09-30 Source
- Operating cash flow: -601153 USD · 2018-04-01 – 2019-03-31 Source
- Operating cash flow: -482875 USD · 2018-04-01 – 2018-12-31 Source
- Operating cash flow: -152987 USD · 2019-04-01 – 2019-06-30 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2019-08-20.
Financial data available through: 2019-03-31.
Coverage by financial measure
- Revenue: 2 of 11 periods available· newest 2019-03-31
- Operating income: 5 of 11 periods available· newest 2019-03-31
- Net income: 5 of 11 periods available· newest 2018-03-31
- Operating cash flow: 6 of 11 periods available· newest 2019-03-31
- capital expenditure: No compatible figures in this window
- Total assets: 2 of 11 periods available· newest 2019-03-31
- Total liabilities: 2 of 11 periods available· newest 2019-03-31
- Current assets: 2 of 11 periods available· newest 2019-03-31
- Current liabilities: 2 of 11 periods available· newest 2019-03-31
- Cash and cash equivalents: 2 of 11 periods available· newest 2019-03-31
- long term debt: No compatible figures in this window
- Shares outstanding: 2 of 11 periods available· newest 2019-03-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+242.5%Prior period
USD 1,429
–
Current period
USD 4,894
–
Exact inputs and evidence
4894 − 1429 = 3465 USD
1429 USD · 2017-04-01 – 2018-03-31
Inspect prior input Prior source4894 USD · 2018-04-01 – 2019-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 263,145Prior period
−USD 338,008
–
Current period
−USD 601,153
–
Exact inputs and evidence
-601153 − -338008 = -263145 USD
-338008 USD · 2017-04-01 – 2018-03-31
Inspect prior input Prior source-601153 USD · 2018-04-01 – 2019-03-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Net income, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2019 2018-04-01 – 2019-03-31
- Revenue USD 4,894 100% of revenue
- Cost of revenue USD 4,043 83% of revenue
- Operating expenses USD 970,890 19,838% of revenue
- Operating income −USD 970,039 −19,821% of revenue
- Tax, interest and other Derived Unavailable An input is unavailable.
- Net income Unavailable An input is unavailable.
Cash
- Operating cash flow −USD 601,153 −12,283% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2018 Operating loss: operating costs were 26,800% of revenue.
- 2019 Not shown: operating income or net income is not reported.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2018 2017-04-01 – 2018-03-31 | 1429 | 382974 Derived | -381545 | 511572 Derived | -893117 | Unavailable | Source
|
| 2019 2018-04-01 – 2019-03-31 | 4894 | 974933 Derived | -970039 | Unavailable | Unavailable | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 4.9K 2019
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Revenue | 1429 |
|
| 2019 | Revenue | 4894 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
242.5% 2019
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | 242.5% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -19,821% 2019
Net margin -62,499.4% 2018
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Operating margin | -26,700.1% |
|
| 2019 | Operating margin | -19,821% |
|
| 2018 | Net margin | -62,499.4% |
|
| 2019-03-31 | Net margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -601.2K 2019
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Operating cash flow | -338008 |
|
| 2019 | Operating cash flow | -601153 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
736.6% 2019
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Liabilities / assets | 402.1% |
|
| 2019 | Liabilities / assets | 736.6% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.1× 2019
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2018 | Current assets / current liabilities | 0.25× |
|
| 2019 | Current assets / current liabilities | 0.1× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2014 2013-04-01 – 2014-03-31 | −USD 50,947 Exact valueExact value: -50947 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 50,847 Exact valueExact value: -50847 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2015 2014-04-01 – 2015-03-31 | −USD 22,438 Exact valueExact value: -22438 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 19,358 Exact valueExact value: -19358 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2016 2015-04-01 – 2016-03-31 | −USD 15,564 Exact valueExact value: -15564 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 15,344 Exact valueExact value: -15344 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2016-04-01 – 2017-03-31 | −USD 21,293 Exact valueExact value: -21293 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 12,695 Exact valueExact value: -12695 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2017-04-01 – 2018-03-31 | −USD 893,117 Exact valueExact value: -893117 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 338,008 Exact valueExact value: -338008 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-04-01 – 2019-03-31 | Unavailable Not reported for this period. | −USD 601,153 Exact valueExact value: -601153 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
32 filings · 849 latest values · 849 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001576724, 1576724, edgar:1576724
Also known as Vilacto Bio Inc., ZLATO INC., Zlato Inc.